Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Chamoto

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
JCI Insight|April 8, 2025
ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesisMari Yokoi, Kosaku Murakami, Tomonori Yaguchi, et al.
International Immunology|September 8, 2004
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiationAkihiko Hoshino, Takemasa Tsuji, Junko Matsuzaki, et al.
International Immunopharmacology|August 13, 2009
Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in miceMegumi Goto, Yoshitaka Tanaka, Masao Murakawa, et al.
JCI Insight|December 20, 2019
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapyRyusuke Hatae, Kenji Chamoto, Young Hak Kim, et al.
British Journal of Cancer|November 2, 2018
VISTA expressed in tumour cells regulates T cell functionKumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, et al.
Nature Communications|February 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancerKatsuhiro Ito, Kei Iida, Tomoko Hirano, et al.
Journal of the American Chemical Society|January 10, 2025
Covalent Plant Natural Product that Potentiates Antitumor ImmunityMisao Takemoto, Sara Delghandi, Masahiro Abo, et al.
Scientific Reports|July 14, 2019
Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasmaMegumi Goto, Kenji Chamoto, Keiko Higuchi, et al.
Frontiers in Immunology|December 27, 2023
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective studyTakashi Kurosaki, Kenji Chamoto, Shinichiro Suzuki, et al.
Nature Immunology|January 7, 2026
Active aldehydes accelerate CD8<sup>+</sup> T cell exhaustion by metabolic alteration in the tumor microenvironmentYasuharu Haku, Koji Kitaoka, Koki Ichimaru, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
JCI Insight|April 8, 2025
ICOS+CD4+ T cells define a high susceptibility to anti-PD-1 therapy-induced lung pathogenesisMari Yokoi, Kosaku Murakami, Tomonori Yaguchi, et al.
International Immunology|September 8, 2004
STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiationAkihiko Hoshino, Takemasa Tsuji, Junko Matsuzaki, et al.
International Immunopharmacology|August 13, 2009
Inhibition of phosphodiesterase 7A ameliorates Concanavalin A-induced hepatitis in miceMegumi Goto, Yoshitaka Tanaka, Masao Murakawa, et al.
JCI Insight|December 20, 2019
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapyRyusuke Hatae, Kenji Chamoto, Young Hak Kim, et al.
British Journal of Cancer|November 2, 2018
VISTA expressed in tumour cells regulates T cell functionKumuluzi Mulati, Junzo Hamanishi, Noriomi Matsumura, et al.
Nature Communications|February 17, 2026
Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancerKatsuhiro Ito, Kei Iida, Tomoko Hirano, et al.
Journal of the American Chemical Society|January 10, 2025
Covalent Plant Natural Product that Potentiates Antitumor ImmunityMisao Takemoto, Sara Delghandi, Masahiro Abo, et al.
Scientific Reports|July 14, 2019
Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasmaMegumi Goto, Kenji Chamoto, Keiko Higuchi, et al.
Frontiers in Immunology|December 27, 2023
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective studyTakashi Kurosaki, Kenji Chamoto, Shinichiro Suzuki, et al.
Nature Immunology|January 7, 2026
Active aldehydes accelerate CD8<sup>+</sup> T cell exhaustion by metabolic alteration in the tumor microenvironmentYasuharu Haku, Koji Kitaoka, Koki Ichimaru, et al.
Pageof 11